a developer of intravascular lithotripsy equipment for treating hardened coronary and peripheral artery disease, were announced by Boston Scientific Corporation (BSX, Financials). Along with ...

Boston Scientific said Wednesday it has agreed to acquire Bolt Medical, paying up to $664 million for the 74% of the cardiovascular company it does not own. The price consists of a $443 million ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 2% over the past month. The stock hit a new 52-week high of $92.42 in the ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Boston Scientific. (2025, January 13). Boston Scientific announces agreement to acquire Bolt ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + CEO Mike Mahoney expects more growth for the company in 2025.

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and ...